Answers are grounded in this paper and cite their sources.
The use of bleomycin sulfate as an antineoplastic agent has been limited by its substantial pulmonary toxic effects. The exact incidence and prognosis of bleomycin-pneumonitis is unresolved. Although bleomycin pulmonary toxicity is thought to be dose-related, recent reports have emphasized severe reactions at low doses. Furthermore, severe pulmonary toxicity has been suggested to be progressive, irreversible, and ultimately, fatal. We report clinical, roentgenographic, and pathophysiologic recovery after severe, bleomycin-induced pneumonitis. (JAMA239:2012-2014, 1978)
No takes yet. Share an insight, caveat, or question.
Brown et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: